Evidence map›Paper›PMID 40807482›Full record

ReviewMolecules (Basel, Switzerland)2025

Challenges, Unmet Needs, and Future Directions for Nanocrystals in Dermal Drug Delivery.

Muzn Alkhaldi, Cornelia M Keck

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Muzn AlkhaldiDepartment of Pharmaceutics and Biopharmaceutics, Marburg University, Robert-Koch-Str. 4, 35037 Marburg, Germany.ORCID 0009-0004-6724-0954
Cornelia M KeckDepartment of Pharmaceutics and Biopharmaceutics, Marburg University, Robert-Koch-Str. 4, 35037 Marburg, Germany.ORCID 0000-0001-8888-2340

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanocrystals, defined as crystalline particles with dimensions in the nanometer range (<1000 nm), exhibit unique properties that enhance the efficacy of poorly soluble active compounds. This review explores the fundamental aspects of nanocrystals, including their characteristics and various preparation methods, while addressing critical factors that influence their stability and incorporation into final products. A key focus of the review is the advantages offered by nanocrystals in dermal applications. It also highlights their ability to enhance passive diffusion into the skin and facilitate penetration via particle-assisted dermal penetration. Additionally, the review discusses their capacity to penetrate into hair follicles, enabling targeted drug delivery, and their synergistic potential when combined with microneedles, which further enhance the dermal absorption of active compounds. The review also addresses several commercial products that successfully employ nanocrystal technology, showcasing its practical applications. Summary: Nanocrystals with their special properties are an emerging trend for dermal applications, particularly the development of plantCrystals-natural nanocrystals sourced from plant materials-which represent a promising path for future research and formulation strategies. These advancements could lead to more sustainable and effective dermal products.

Indexed as

Drug Delivery SystemsNanoparticlesSkinAdministration, CutaneousAnimalsHumansSkin Absorptiondermal drug deliveryhair follicle targetinghigh-pressure homogenizationnanocrystalsplantCrystalssolubility

Identifiers

PMID40807482
PMCPMC12348241

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.